日本のがんバイオマーカー市場レポート プロファイリング技術(オミクス技術、イメージング技術、イムノアッセイ、細胞遺伝学)、バイオ分子(遺伝的バイオマーカー、タンパク質バイオマーカー、グリコバイオマーカー)、がんの種類(乳がん、肺がん、大腸がん、前立腺がん、胃がん、その他)、用途(診断、予後、リスク評価、薬剤の発見・開発、その他)、エンドユーザー(病院、学術研究機関、外来手術センター、診断検査室、その他)、および地域別 2025年から2033年

日本のがんバイオマーカー市場レポート プロファイリング技術(オミクス技術、イメージング技術、イムノアッセイ、細胞遺伝学)、バイオ分子(遺伝的バイオマーカー、タンパク質バイオマーカー、グリコバイオマーカー)、がんの種類(乳がん、肺がん、大腸がん、前立腺がん、胃がん、その他)、用途(診断、予後、リスク評価、薬剤の発見・開発、その他)、エンドユーザー(病院、学術研究機関、外来手術センター、診断検査室、その他)、および地域別 2025年から2033年

Report Format: PDF+Excel | Report ID: SR112025A27299

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface 
2   Scope and Methodology 

    2.1    Objectives of the Study 
    2.2    Stakeholders 
    2.3    Data Sources 
        2.3.1    Primary Sources 
        2.3.2    Secondary Sources 
    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach 
        2.4.2    Top-Down Approach 
    2.5    Forecasting Methodology 
3   Executive Summary 
4   Japan Cancer Biomarkers Market - Introduction 

    4.1    Overview 
    4.2    Market Dynamics 
    4.3    Industry Trends 
    4.4    Competitive Intelligence 
5   Japan Cancer Biomarkers Market Landscape 
    5.1    Historical and Current Market Trends (2019-2024) 
    5.2    Market Forecast (2025-2033) 
6   Japan Cancer Biomarkers Market - Breakup by Profiling Technology
    6.1    Omic Technologies
        6.1.1 Overview 
        6.1.2 Historical and Current Market Trends (2019-2024) 
        6.1.3 Market Forecast (2025-2033) 
    6.2    Imaging Technologies
        6.2.1 Overview 
        6.2.2 Historical and Current Market Trends (2019-2024) 
        6.2.3 Market Forecast (2025-2033) 
    6.3    Immunoassays
        6.3.1 Overview 
        6.3.2 Historical and Current Market Trends (2019-2024) 
        6.3.3 Market Forecast (2025-2033) 
    6.4    Cytogenetics
        6.4.1 Overview 
        6.4.2 Historical and Current Market Trends (2019-2024) 
        6.4.3 Market Forecast (2025-2033) 
7   Japan Cancer Biomarkers Market - Breakup by Biomolecule
    7.1    Genetic Biomarkers
        7.1.1 Overview 
        7.1.2 Historical and Current Market Trends (2019-2024) 
        7.1.3 Market Forecast (2025-2033) 
    7.2    Protein Biomarkers
        7.2.1 Overview 
        7.2.2 Historical and Current Market Trends (2019-2024) 
        7.2.3 Market Forecast (2025-2033) 
    7.3    Glyco-Biomarkers
        7.3.1 Overview 
        7.3.2 Historical and Current Market Trends (2019-2024) 
        7.3.3 Market Forecast (2025-2033) 
8   Japan Cancer Biomarkers Market - Breakup by Cancer Type
    8.1    Breast Cancer
        8.1.1 Overview 
        8.1.2 Historical and Current Market Trends (2019-2024) 
        8.1.3 Market Forecast (2025-2033) 
    8.2    Lung Cancer
        8.2.1 Overview 
        8.2.2 Historical and Current Market Trends (2019-2024) 
        8.2.3 Market Forecast (2025-2033) 
    8.3    Colorectal Cancer
        8.3.1 Overview 
        8.3.2 Historical and Current Market Trends (2019-2024) 
        8.3.3 Market Forecast (2025-2033) 
    8.4    Prostate Cancer
        8.4.1 Overview 
        8.4.2 Historical and Current Market Trends (2019-2024) 
        8.4.3 Market Forecast (2025-2033) 
    8.5    Stomach Cancer
        8.5.1 Overview 
        8.5.2 Historical and Current Market Trends (2019-2024) 
        8.5.3 Market Forecast (2025-2033) 
    8.6    Others
        8.6.1 Historical and Current Market Trends (2019-2024) 
        8.6.2 Market Forecast (2025-2033) 
9   Japan Cancer Biomarkers Market - Breakup by Application
    9.1    Diagnostics
        9.1.1 Overview 
        9.1.2 Historical and Current Market Trends (2019-2024) 
        9.1.3 Market Forecast (2025-2033) 
    9.2    Prognostics
        9.2.1 Overview 
        9.2.2 Historical and Current Market Trends (2019-2024) 
        9.2.3 Market Forecast (2025-2033) 
    9.3    Risk Assessment
        9.3.1 Overview 
        9.3.2 Historical and Current Market Trends (2019-2024) 
        9.3.3 Market Forecast (2025-2033) 
    9.4    Drug Discovery and Development
        9.4.1 Overview 
        9.4.2 Historical and Current Market Trends (2019-2024) 
        9.4.3 Market Forecast (2025-2033) 
    9.5    Others
        9.5.1 Historical and Current Market Trends (2019-2024) 
        9.5.2 Market Forecast (2025-2033) 
10   Japan Cancer Biomarkers Market - Breakup by End User
    10.1    Hospitals
        10.1.1 Overview 
        10.1.2 Historical and Current Market Trends (2019-2024) 
        10.1.3 Market Forecast (2025-2033) 
    10.2    Academic and Research Institutions
        10.2.1 Overview 
        10.2.2 Historical and Current Market Trends (2019-2024) 
        10.2.3 Market Forecast (2025-2033)  
    10.3    Ambulatory Surgical Centers
        10.3.1 Overview 
        10.3.2 Historical and Current Market Trends (2019-2024) 
        10.3.3 Market Forecast (2025-2033) 
    10.4    Diagnostic Laboratories
        10.4.1 Overview 
        10.4.2 Historical and Current Market Trends (2019-2024) 
        10.4.3 Market Forecast (2025-2033) 
    10.5    Others
        10.5.1 Historical and Current Market Trends (2019-2024) 
        10.5.2 Market Forecast (2025-2033) 
11   Japan Cancer Biomarkers Market – Breakup by Region
    11.1    Kanto Region
        11.1.1 Overview 
        11.1.2 Historical and Current Market Trends (2019-2024) 
        11.1.3 Market Breakup by Profiling Technology 
        11.1.4 Market Breakup by Biomolecule 
        11.1.5 Market Breakup by Cancer Type
        11.1.6 Market Breakup by Service
        11.1.7 Market Breakup by End User 
        11.1.8 Key Players 
        11.1.9 Market Forecast (2025-2033) 
    11.2    Kansai/Kinki Region
        11.2.1 Overview 
        11.2.2 Historical and Current Market Trends (2019-2024) 
        11.2.3 Market Breakup by Profiling Technology 
        11.2.4 Market Breakup by Biomolecule 
        11.2.5 Market Breakup by Cancer Type
        11.2.6 Market Breakup by Service
        11.2.7 Market Breakup by End User 
        11.2.8 Key Players 
        11.2.9 Market Forecast (2025-2033) 
    11.3    Central/ Chubu Region
        11.3.1 Overview 
        11.3.2 Historical and Current Market Trends (2019-2024) 
        11.3.3 Market Breakup by Profiling Technology 
        11.3.4 Market Breakup by Biomolecule 
        11.3.5 Market Breakup by Cancer Type
        11.3.6 Market Breakup by Service
        11.3.7 Market Breakup by End User 
        11.3.8 Key Players 
        11.3.9 Market Forecast (2025-2033) 
    11.4    Kyushu-Okinawa Region 
        11.4.1 Overview 
        11.4.2 Historical and Current Market Trends (2019-2024) 
        11.4.3 Market Breakup by Profiling Technology 
        11.4.4 Market Breakup by Biomolecule 
        11.4.5 Market Breakup by Cancer Type
        11.4.6 Market Breakup by Service
        11.4.7 Market Breakup by End User 
        11.4.8 Key Players 
        11.4.9 Market Forecast (2025-2033)
    11.5    Tohoku Region
        11.5.1 Overview 
        11.5.2 Historical and Current Market Trends (2019-2024) 
        11.5.3 Market Breakup by Profiling Technology 
        11.5.4 Market Breakup by Biomolecule 
        11.5.5 Market Breakup by Cancer Type
        11.5.6 Market Breakup by Service
        11.5.7 Market Breakup by End User 
        11.5.8 Key Players 
        11.5.9 Market Forecast (2025-2033)  
    11.6    Chugoku Region
        11.6.1 Overview 
        11.6.2 Historical and Current Market Trends (2019-2024) 
        11.6.3 Market Breakup by Profiling Technology 
        11.6.4 Market Breakup by Biomolecule 
        11.6.5 Market Breakup by Cancer Type
        11.6.6 Market Breakup by Service
        11.6.7 Market Breakup by End User 
        11.6.8 Key Players 
        11.6.9 Market Forecast (2025-2033)
    11.7    Hokkaido Region
        11.7.1 Overview 
        11.7.2 Historical and Current Market Trends (2019-2024) 
        11.7.3 Market Breakup by Profiling Technology 
        11.7.4 Market Breakup by Biomolecule 
        11.7.5 Market Breakup by Cancer Type
        11.7.6 Market Breakup by Service
        11.7.7 Market Breakup by End User 
        11.7.8 Key Players 
        11.7.9 Market Forecast (2025-2033) 
    11.8    Shikoku Region
        11.8.1 Overview 
        11.8.2 Historical and Current Market Trends (2019-2024) 
        11.8.3 Market Breakup by Profiling Technology 
        11.8.4 Market Breakup by Biomolecule 
        11.8.5 Market Breakup by Cancer Type
        11.8.6 Market Breakup by Service
        11.8.7 Market Breakup by End User 
        11.8.8 Key Players 
        11.8.9 Market Forecast (2025-2033)  
12   Japan Cancer Biomarkers Market – Competitive Landscape 
    12.1    Overview 
    12.2    Market Structure 
    12.3    Market Player Positioning 
    12.4    Top Winning Strategies 
    12.5    Competitive Dashboard 
    12.6    Company Evaluation Quadrant 
13   Profiles of Key Players 
    13.1    Company A  
        13.1.1 Business Overview 
        13.1.2 Product Portfolio 
        13.1.3 Business Strategies 
        13.1.4 SWOT Analysis 
        13.1.5 Major News and Events 
    13.2    Company B 
        13.2.1 Business Overview 
        13.2.2 Product Portfolio 
        13.2.3 Business Strategies 
        13.2.4 SWOT Analysis 
        13.2.5 Major News and Events 
    13.3    Company C 
        13.3.1 Business Overview 
        13.3.2 Product Portfolio 
        13.3.3 Business Strategies 
        13.3.4 SWOT Analysis 
        13.3.5 Major News and Events 
    13.4    Company D  
        13.4.1 Business Overview 
        13.4.2 Product Portfolio 
        13.4.3 Business Strategies 
        13.4.4 SWOT Analysis 
        13.4.5 Major News and Events 
    13.5    Company E 
        13.5.1 Business Overview 
        13.5.2 Product Portfolio 
        13.5.3 Business Strategies 
        13.5.4 SWOT Analysis 
        13.5.5 Major News and Events     
 
Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report. 
 
14   Japan Cancer Biomarkers Market - Industry Analysis 

    14.1    Drivers, Restraints, and Opportunities 
        14.1.1 Overview 
        14.1.2 Drivers 
        14.1.3 Restraints 
        14.1.4 Opportunities 
    14.2   Porters Five Forces Analysis 
        14.2.1 Overview 
        14.2.2 Bargaining Power of Buyers 
        14.2.3 Bargaining Power of Suppliers 
        14.2.4 Degree of Competition 
        14.2.5 Threat of New Entrants 
        14.2.6 Threat of Substitutes 
    14.3    Value Chain Analysis 
15   Appendix

日本のがんバイオマーカー市場レポート プロファイリング技術(オミクス技術、イメージング技術、イムノアッセイ、細胞遺伝学)、バイオ分子(遺伝的バイオマーカー、タンパク質バイオマーカー、グリコバイオマーカー)、がんの種類(乳がん、肺がん、大腸がん、前立腺がん、胃がん、その他)、用途(診断、予後、リスク評価、薬剤の発見・開発、その他)、エンドユーザー(病院、学術研究機関、外来手術センター、診断検査室、その他)、および地域別 2025年から2033年
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials